Kopp Family Office’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-55,295
Closed -$1.08M 30
2026
Q1
$1.08M Sell
55,295
-117,878
-68% -$3.5M 0.74% 16
2025
Q4
$5.39M Sell
173,173
-20,657
-11% -$567K 3.44% 9
2025
Q3
$4.18M Sell
193,830
-9,400
-5% -$170K 2.72% 14
2025
Q2
$2.84M Sell
203,230
-2,177
-1% -$29.5K 1.84% 18
2025
Q1
$2.77M Hold
205,407
1.91% 16
2024
Q4
$3.94M Sell
205,407
-330
-0.2% -$7.17K 2.5% 12
2024
Q3
$4.68M Hold
205,737
2.98% 13
2024
Q2
$2.68M Buy
205,737
+97
+0% +$1.34K 1.66% 12
2024
Q1
$3.6M Buy
205,640
+40
+0% +$775 2.06% 12
2023
Q4
$4.48M Sell
205,600
-8,690
-4% -$137K 2.62% 12
2023
Q3
$3.29M Hold
214,290
2.08% 12
2023
Q2
$5.1M Buy
214,290
+83,002
+63% +$2.13M 2.74% 12
2023
Q1
$3.34M Buy
131,288
+66,900
+104% +$2.15M 1.8% 12
2022
Q4
$1.88M Buy
+64,388
New +$1.48M 1.13% 11

Other funds holding VRDN